Identification of a novel lysyl oxidase-like 2 alternative splicing isoform, LOXL2 Δe13, in esophageal squamous cell carcinoma.
about
Splicing Regulators and Their Roles in Cancer Biology and TherapyLysyl Oxidase Isoforms and Potential Therapeutic Opportunities for Fibrosis and Cancer.A three-gene signature from protein-protein interaction network of LOXL2- and actin-related proteins for esophageal squamous cell carcinoma prognosis.SLC52A3 expression is activated by NF-κB p65/Rel-B and serves as a prognostic biomarker in esophageal cancer.Exploration of potential roles of a new LOXL2 splicing variant using network knowledge in esophageal squamous cell carcinoma.F806 Suppresses the Invasion and Metastasis of Esophageal Squamous Cell Carcinoma via Downregulating F-Actin Assembly-Related Rho Family Proteins
P2860
Identification of a novel lysyl oxidase-like 2 alternative splicing isoform, LOXL2 Δe13, in esophageal squamous cell carcinoma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Identification of a novel lysy ...... ageal squamous cell carcinoma.
@en
type
label
Identification of a novel lysy ...... ageal squamous cell carcinoma.
@en
prefLabel
Identification of a novel lysy ...... ageal squamous cell carcinoma.
@en
P2093
P2860
P356
P1476
Identification of a novel lysy ...... ageal squamous cell carcinoma.
@en
P2093
Bing-Li Wu
Fa-Min Zeng
Guo-Qing Lv
Hai-Ying Zou
Hui-Hui Cao
Jian-Jun Xie
Lian-Di Liao
Wang-Kai Fang
P2860
P304
P356
10.1139/BCB-2014-0046
P577
2014-08-05T00:00:00Z